Biogen

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Biogen and other ETFs, options, and stocks.

About BIIB

Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS, SPINRAZA for the treatment of SMA, ADUHELM for the treatment of Alzheimer's disease, and FUMADERM for the treatment of severe plaque psoriasis. 

CEO
Christopher A. Viehbacher
CEOChristopher A. Viehbacher
Employees
7,570
Employees7,570
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
1978
Founded1978
Employees
7,570
Employees7,570

BIIB Key Statistics

Market cap
31.98B
Market cap31.98B
Price-Earnings ratio
27.13
Price-Earnings ratio27.13
Dividend yield
Dividend yield
Average volume
1.35M
Average volume1.35M
High today
$217.57
High today$217.57
Low today
$214.00
Low today$214.00
Open price
$217.36
Open price$217.36
Volume
1.91M
Volume1.91M
52 Week high
$319.76
52 Week high$319.76
52 Week low
$211.02
52 Week low$211.02

BIIB News

Investor's Business Daily 12h
Alzheimer's Disease: The Treatment Battle Heats Up Despite Eli Lilly's Setback - Investor's Business Daily

The quest to treat Alzheimer's disease is heating up as drugmakers Eli Lilly (LLY), Biogen (BIIB) and Roche (RHHBY) blaze new trails. But there are speed bumps...

Alzheimer's Disease: The Treatment Battle Heats Up Despite Eli Lilly's Setback - Investor's Business Daily
Yahoo Finance 2d
CHMP to Delay Nod on Biogen, Eisai's Alzheimer's Drug - Yahoo Finance

Biogen BIIB and partner Eisai recently announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has delayed th...

CHMP to Delay Nod on Biogen, Eisai's Alzheimer's Drug - Yahoo Finance
Yahoo Finance 3d
Indivi to Collaborate with Biogen to Advance Digital Health Technology and Digital Biomarkers for Parkinson's Disease - Yahoo Finance

BASEL, Switzerland, March 26, 2024--(BUSINESS WIRE)--Indivi, a leading MedTech company headquartered in Basel, Switzerland, has entered into an agreement with B...

Indivi to Collaborate with Biogen to Advance Digital Health Technology and Digital Biomarkers for Parkinson's Disease - Yahoo Finance

Analyst ratings

74%

of 35 ratings
Buy
74.3%
Hold
25.7%
Sell
0%

More BIIB News

Yahoo Finance 3d
Biogen Inc. Dips More Than Broader Market: What You Should Know - Yahoo Finance

Biogen Inc. (BIIB) closed at $216.69 in the latest trading session, marking a -0.65% move from the prior day. This change lagged the S&P 500's daily loss of 0.3...

Biogen Inc. Dips More Than Broader Market: What You Should Know - Yahoo Finance
Benzinga 3d
Forecasting The Future: 18 Analyst Projections For Biogen - Biogen - Benzinga

Loading... Loading... During the last three months, 18 analysts shared their evaluations of Biogen BIIB, revealing diverse outlooks from bullish to bearish. T...

Forecasting The Future: 18 Analyst Projections For Biogen - Biogen - Benzinga
Yahoo Finance 4d
Labcorp Boost Diagnostics Suite With New Biomarker Test - Yahoo Finance

Laboratory Corporation of America Holdings, Inc. or Labcorp LH recently launched a new blood test that detects phosphorylated tau 217 (pTau217) — a biomarker fo...

Labcorp Boost Diagnostics Suite With New Biomarker Test - Yahoo Finance
TipRanks 6d
Eisai says CHMP oral explanation for lecanemab rescheduled

Biogen (BIIB) noted that Eisai (ESAIY) announced an update on the regulatory review process of lecanemab by the European Medicines Agency, or EMA. Eisai announc...

Reuters 7d
UPDATE 2-EU regulator delays decision on Eisai-Biogen Alzheimer's drug

(Rewrites with comment from Eisai, adds background in paragraph 6, comment from EMA in paragraph 5) March 22 (Reuters) - The European Union's medicines regulat...

UPDATE 2-EU regulator delays decision on Eisai-Biogen Alzheimer's drug
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.